Subthreshold Cannabidiol Potentiates Levetiracetam in the Kainic Acid Model of Temporal Lobe Epilepsy: A Pilot Study
Refractoriness to antiseizure medications is still a major concern in the pharmacotherapy of epilepsy. For this reason, we decided to evaluate the combination of levetiracetam and cannabidiol, administered at a subthreshold dose, to limit the possible adverse effects of this phytocannabinoid. We adm...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-09-01
|
| סדרה: | Pharmaceuticals |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1424-8247/17/9/1187 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
